Gene CMO

Bio & Pharma Samsung Biologics bags $514 mn CMO contract from US pharma

Samsung Biologics Co., the world’s largest contract manufacturing organization (CMO), said on Monday it has secured a $5.14 million order from...

Bio & Pharma Samsung Biologics signs $1.4 bn CMO deal with European pharma

South Korea's Samsung Biologics Co., the world’s largest contract drugmaker, said on Tuesday it signed a $1.4 billion contract manufacturing o...

Bio & Pharma Samsung’s biotech duo on a roll with $1.1 bn CMO order

Samsung Group is on track to rise to the top of biosimilar companies in the world and become South Korea’s largest drug maker for contract man...

Bio & Pharma Samsung Life Science invests in US biotech firm Latus Bio

Samsung Life Science Fund, managed by Samsung Group’s venture investment arm, has invested in US biotechnology firm Latus Bio Inc. during the ...

Bio & Pharma Samsung invests in BrickBio in US

Samsung Group announced on Tuesday that its Life Science Fund has invested in the US-based antibody-drug conjugates (ADC) and gene therapy technol...

Bio & Pharma Samsung targets gene therapy sector through US investments

Samsung Group is targeting the gene therapy business through investments in US biotechnology companies as the leading South Korean conglomerate is s...

Bio & Pharma ToolGen gets FDA approval for TGT-001 as ODD

South Korean genome editing developer ToolGen Inc. announced on Monday that its application for orphan drug designation (ODD) of the gene correction...

Bio & Pharma Samsung Biologics reaches record-breaking annual orders

Samsung Biologics Co., the world’s top contract manufacturing organization (CMO) by capacity, surpassed the annual contract manufacturing orde...

Bio & Pharma Dong-A ST, UMass to jointly research for gene therapy

South Korea's Dong-A ST announced on Friday it has signed a joint research agreement with the University of Massachusetts (UMass) Chan Medical Schoo...

Mergers & Acquisitions SK becomes top shareholder of US contract drug maker CBM

SK Pharmteco Co., a South Korean contract development and manufacturing organization (CDMO), said on Wednesday it has secured management rights of t...

Korean stock market KCGI Asset Management appoints former KIS head as new CMO

South Korea’s KCGI Asset Management, formerly Meritz Asset Management, announced on Friday that it has hired Cho Won-bok, former division head...

Bio & Pharma SK Bioscience buys 6.5 million Novavax shares for $83.4 million

SK Bioscience Co., the drug-making unit of South Korea’s SK Group, said on Wednesday it has signed a deal to buy 6.5 million shares in US vacc...

Bio & Pharma S.Korea's ToolGen develops gene-edited cow for artificial blood

South Korean genome editing developer ToolGen Inc. has teamed up with Lartbio Technology, a Seoul-based transgenic animal development company, to de...

Construction Hyundai E&C to develop future residential model All Life-care House

South Korea's Hyundai Engineering & Construction (Hyundai E&C) has announced plans to create a future residential model, the All Life-care H...

Beauty & Cosmetics LabGenomics, Amorepacific sign gene testing service supply deal

South Korea's molecular diagnostics company LabGenomics Co. announced on Monday that it has signed a gene testing service supply contract with Amore...

Bio & Pharma S.Korea's iNtRON launches halal test kit to target Middle Eastern market

South Korean biotech firm iNtRON Biotechnology Inc. is focusing on the Middle Eastern market with the introduction of its "LiliF Halal Real-time PCR...

Bio & Pharma Korea's ST Pharm completes new R&D hub for gene therapy

ST Pharm Co., a South Korean drug raw material-producing subsidiary of Dong-A Socio Holdings, said on Friday that it has finished building an R&...

Bio & Pharma Samsung Biologics bags $183 million CMO order from Pfizer

Samsung Biologics Co., the world’s No. 1 contract drug maker in terms of production capacity, has won a $182.7 million contract manufacturing ...

Bio & Pharma Brazil approves Celltrion Pharm’s syringe facility

Celltrion Pharm Inc., a South Korean biopharmaceutical company, said on Monday it received certification from Brazil’s health regulator for it...

Bio & Pharma Kolon signs MOU with Hanyang Univ. to develop gene therapy treatments

Kolon Industries Inc.'s Future Technology Institute said on Thursday that it had signed a memorandum of understanding with the Hanyang University In...

Bio & Pharma ToolGen, ANLBIO to jointly develop progeria treatments

South Korea's two biotech startups ToolGen Incorporated and ANLBIO on Tuesday signed a joint research and development agreement for developing proge...

Bio & Pharma Seegene's COVID-19 diagnostic product wins Product of the Year Award

Seegene Inc. said on Friday that its COVID-19 diagnostic product Allplex SARS-CoV-2 Assay received the Product of the Year Award at the BioSpectrum ...

Bio & Pharma Samsung Biologics in CDO deal talks with global pharma firm

FRANKFURT – Samsung Biologics Co., the world’s largest contract drugmaker, is in talks to develop medicines for a global pharmaceutical ...

Bio & Pharma Korea's Samsung Biologics signs $296 mn CMO deal with GSK

South Korea’s Samsung Biologics Co. has signed a $296.1 million deal to supply biopharmaceutical products to UK-based multinational pharma gia...

Bio & Pharma K-bio firms embrace gene therapy CDMO as Samsung looks the other way

South Korea’s major biopharmaceutical companies are rapidly embracing the cell and gene therapy business under a contract drug-making mechanis...

Bio & Pharma Samsung Biologics signs $81 mn CMO deal with Novartis

South Korea’s Samsung Biologics Co. has inked an $81 million contract manufacturing deal with Novartis, the world’s fifth-largest pharma...

Bio & Pharma Kolon Life inks technology transfer deal with Juniper Biologics

South Korea’s pharmaceutical company Kolon Life Science Inc. signed a technology export deal worth up to 723.4 billion won ($589.1 million) wi...

Bio & Pharma SK Bioscience seeks multi-billion-dollar M&As, eyes gene therapy sector

SK Bioscience Co., the biopharmaceutical unit of South Korea’s SK Group, is seeking multi-billion-dollar mergers and acquisitions to expand it...

Bio & Pharma Samsung’s Life Science Fund invests in US biotech Jaguar Gene Therapy

Samsung Group’s 150 billion won ($124 million) Life Science Fund launched last year has chosen a leading US gene therapy development company a...

Pre-IPOs SK Pharmteco to raise up to $498 mn on $5 bn valuation

SK Pharmteco, a contract development and manufacturing organization (CDMO) for pharmaceuticals, is slated to raise 400 billion ($332.2 million) to 6...